Cardiff Oncology (CRDF) Other Operating Expenses (2012 - 2018)

Cardiff Oncology has reported Other Operating Expenses for 7 years, with the latest figure at $26677.0 in Q3 2018.

• Quarterly Other Operating Expenses fell 94.36% year-over-year to $26677.0 in Q3 2018, while the trailing twelve-month figure through Jun 2019 was $26677.0 (down 98.17% YoY) and the FY2020 annual result came in at -$28244.0, down 1527.91% from the prior year.
• Other Operating Expenses fell to $26677.0 in Q3 2018 per CRDF's latest filing, from $204436.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $6.3 million in Q4 2015 and troughed at -$19255.0 in Q3 2014.
• A 5-year average of $1.6 million and a median of $473202.0 in 2017 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2014 and 2016: Other Operating Expenses tumbled 102.1% in 2014, then jumped 98476.26% in 2016.
• Over 5 years, Other Operating Expenses stood at -$19255.0 in 2014, then jumped by 32735.64% to $6.3 million in 2015, then plunged by 85.87% to $888184.0 in 2016, then plunged by 53.41% to $413764.0 in 2017, then sank by 93.55% to $26677.0 in 2018.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $26677.0, $204436.0, and $366344.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.